{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T08:09:08Z","timestamp":1780474148042,"version":"3.54.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,3,5]],"date-time":"2018-03-05T00:00:00Z","timestamp":1520208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,3,5]],"date-time":"2018-03-05T00:00:00Z","timestamp":1520208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Johnson and Johnson K.K."},{"name":"Pharmaceuticals and Medical Devices Agency"},{"name":"Abbott Vascular Japan"},{"DOI":"10.13039\/501100008645","name":"Terumo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008645","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Interv and Ther"],"published-print":{"date-parts":[[2019,1,25]]},"DOI":"10.1007\/s12928-018-0517-x","type":"journal-article","created":{"date-parts":[[2018,3,5]],"date-time":"2018-03-05T06:08:11Z","timestamp":1520230091000},"page":"47-58","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Mortality impact of post-discharge myocardial infarction size after percutaneous coronary intervention: a patient-level pooled analysis from the 4 large-scale Japanese studies"],"prefix":"10.1007","volume":"34","clinical-trial-number":[{"clinical-trial-number":"nct01035450","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01303640","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Hirotoshi","family":"Watanabe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Morimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Shiomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naritatsu","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Shizuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koh","family":"Ono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyohei","family":"Yamaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Ando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuichiro","family":"Kaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaharu","family":"Akao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshito","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiya","family":"Muramatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Suwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihisa","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazushige","family":"Kadota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Takatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Nishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshikazu","family":"Hiasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiko","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunichi","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,5]]},"reference":[{"key":"517_CR1","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1161\/hc3101.093902","volume":"104","author":"GW Stone","year":"2001","unstructured":"Stone GW, Mehran R, Dangas G, Lansky AJ, Kornowski R, Leon MB. Differential impact on survival of electrocardiographic Q-wave versus enzymatic myocardial infarction after percutaneous intervention: a device-specific analysis of 7147 patients. Circulation. 2001;104:642\u20137.","journal-title":"Circulation"},{"key":"517_CR2","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/S0002-8703(03)00095-4","volume":"145","author":"Z Ghazzal","year":"2003","unstructured":"Ghazzal Z, Ashfaq S, Morris DC, Douglas JS, Marshall JJ, King SB, et al. Prognostic implication of creatine kinase release after elective percutaneous coronary intervention in the pre-IIb\/IIIa antagonist era. Am Heart J. 2003;145:1006\u201312.","journal-title":"Am Heart J"},{"key":"517_CR3","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1016\/j.jacc.2004.06.051","volume":"44","author":"A Jeremias","year":"2004","unstructured":"Jeremias A, Baim DS, Ho KKL, Chauhan M, Carrozza JP, Cohen DJ, et al. Differential mortality risk of postprocedural creatine kinase-MB elevation following successful versus unsuccessful stent procedures. J Am Coll Cardiol. 2004;44:1210\u20134.","journal-title":"J Am Coll Cardiol"},{"key":"517_CR4","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.jacc.2009.03.063","volume":"54","author":"A Prasad","year":"2009","unstructured":"Prasad A, Gersh BJ, Bertrand ME, Lincoff AM, Moses JW, Ohman EM, et al. Prognostic significance of periprocedural versus spontaneously occurring myocardial infarction after percutaneous coronary intervention in patients with acute coronary syndromes: an analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) Trial. J Am Coll Cardiol. 2009;54:477\u201386.","journal-title":"J Am Coll Cardiol"},{"key":"517_CR5","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1016\/j.jacc.2015.01.047","volume":"65","author":"DS Kazi","year":"2015","unstructured":"Kazi DS, Leong TK, Chang TI, Solomon MD, Hlatky MA, Go AS. Association of spontaneous bleeding and myocardial infarction with long-term mortality after percutaneous coronary intervention. J Am Coll Cardiol. 2015;65:1411\u201320.","journal-title":"J Am Coll Cardiol"},{"key":"517_CR6","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.jacc.2015.06.1323","volume":"66","author":"P G\u00e9n\u00e9reux","year":"2015","unstructured":"G\u00e9n\u00e9reux P, Giustino G, Witzenbichler B, Weisz G, Stuckey TD, Rinaldi MJ, et al. Incidence, predictors, and impact of post-discharge bleeding after percutaneous coronary intervention. J Am Coll Cardiol. 2015;66:1036\u201345.","journal-title":"J Am Coll Cardiol"},{"key":"517_CR7","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1161\/CIR.0b013e31826e1058","volume":"126","author":"K Thygesen","year":"2012","unstructured":"Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, et al. Third universal definition of myocardial infarction. Circulation. 2012;126:2020\u201335.","journal-title":"Circulation"},{"key":"517_CR8","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1161\/CIRCULATIONAHA.108.808311","volume":"119","author":"T Kimura","year":"2009","unstructured":"Kimura T, Morimoto T, Nakagawa Y, Tamura T, Kadota K, Yasumoto H, et al. Antiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantation. Circulation. 2009;119:987\u201395.","journal-title":"Circulation"},{"key":"517_CR9","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/s12928-011-0065-0","volume":"26","author":"T Kimura","year":"2011","unstructured":"Kimura T, Morimoto T, Furukawa Y, Nakagawa Y, Kadota K, Iwabuchi M, et al. Long-term safety and efficacy of sirolimus-eluting stents versus bare-metal stents in real world clinical practice in Japan. Cardiovasc Interv Ther. 2011;26:234\u201345.","journal-title":"Cardiovasc Interv Ther"},{"key":"517_CR10","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1161\/CIRCULATIONAHA.112.104059","volume":"126","author":"T Kimura","year":"2012","unstructured":"Kimura T, Morimoto T, Natsuaki M, Shiomi H, Igarashi K, Kadota K, et al. Comparison of everolimus-eluting and sirolimus-eluting coronary stents: 1-year outcomes from the randomized evaluation of sirolimus-eluting versus everolimus-eluting stent trial (RESET). Circulation. 2012;126:1225\u201336.","journal-title":"Circulation"},{"key":"517_CR11","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jacc.2013.04.045","volume":"62","author":"M Natsuaki","year":"2013","unstructured":"Natsuaki M, Kozuma K, Morimoto T, Kadota K, Muramatsu T, Nakagawa Y, et al. Biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent: a randomized, controlled, noninferiority trial. J Am Coll Cardiol. 2013;62:181\u201390.","journal-title":"J Am Coll Cardiol"},{"key":"517_CR12","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1056\/NEJM200104123441502","volume":"344","author":"PW Serruys","year":"2001","unstructured":"Serruys PW, Unger F, Sousa JE, Jatene A, Bonnier HJ, Sch\u00f6nberger JP, et al. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med. 2001;344:1117\u201324.","journal-title":"N Engl J Med"},{"key":"517_CR13","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","volume":"115","author":"DE Cutlip","year":"2007","unstructured":"Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, Van Es GA, et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation. 2007;115:2344\u201351.","journal-title":"Circulation"},{"key":"517_CR14","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1080\/01621459.1977.10479903","volume":"72","author":"J Crowley","year":"1977","unstructured":"Crowley J, Hu M. Covariance analysis of heart transplant survival data. J Am Stat Assoc. 1977;72:27\u201336.","journal-title":"J Am Stat Assoc"},{"key":"517_CR15","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1161\/CIRCULATIONAHA.111.041160","volume":"125","author":"MP Bonaca","year":"2012","unstructured":"Bonaca MP, Wiviott SD, Braunwald E, Murphy SA, Ruff CT, Antman EM, et al. American College of Cardiology\/American Heart Association\/European Society of Cardiology\/World Heart Federation universal definition of myocardial infarction classification system and the risk of cardiovascular death: observations from the TRITON-TIMI 38 Trial (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis in Myocardial Infarction 38). Circulation. 2012;125:577\u201383.","journal-title":"Circulation"},{"key":"517_CR16","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1016\/j.jacc.2014.08.037","volume":"64","author":"F Pedersen","year":"2014","unstructured":"Pedersen F, Butrymovich V, Kelb\u00e6k H, Wachtell K, Helqvist S, Kastrup J, et al. Short- and long-term cause of death in patients treated with primary PCI for STEMI. J Am Coll Cardiol. 2014;64:2101\u20138.","journal-title":"J Am Coll Cardiol"},{"key":"517_CR17","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.jacc.2009.06.065","volume":"55","author":"S Kaul","year":"2010","unstructured":"Kaul S, Diamond GA. Trial and error. How to avoid commonly encountered limitations of published clinical trials. J Am Coll Cardiol. 2010;55:415\u201327.","journal-title":"J Am Coll Cardiol"},{"key":"517_CR18","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1056\/NEJMoa1409312","volume":"371","author":"L Mauri","year":"2014","unstructured":"Mauri L, Kereiakes DJ, Yeh RW, Driscoll-Shempp P, Cutlip DE, Steg PG, et al. Twelve or 30\u00a0months of dual antiplatelet therapy after drug-eluting stents. N Engl J Med. 2014;371:2155\u201366.","journal-title":"N Engl J Med"},{"key":"517_CR19","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","volume":"376","author":"MS Sabatine","year":"2017","unstructured":"Sabatine MS, Giugliano RP, Keech AC, Honarpour N, Wiviott SD, Murphy SA, et al. Evolocumab and clinical outcomes in patients with cardiovascular disease. N Engl J Med. 2017;376:1713\u201322.","journal-title":"N Engl J Med"},{"key":"517_CR20","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1172\/JCI109004","volume":"61","author":"SF Vatner","year":"1978","unstructured":"Vatner SF, Baig H, Manders WT, Maroko PR. Effects of coronary artery reperfusion on myocardial infarct size calculated from creatine kinase. J Clin Investig. 1978;61:1048\u201356.","journal-title":"J Clin Investig"},{"key":"517_CR21","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1253\/circj.CJ-15-1181","volume":"80","author":"J Aoki","year":"2016","unstructured":"Aoki J, Kozuma K, Awata M, Nanasato M, Shiode N, Tanabe K, et al. Three-year clinical outcomes of everolimus-eluting stents from the post-marketing surveillance study of cobalt-chromium everolimus-eluting stent (XIENCE V\/PROMUS) in Japan. Circ J. 2016;80:906\u201312.","journal-title":"Circ J"}],"container-title":["Cardiovascular Intervention and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12928-018-0517-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12928-018-0517-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12928-018-0517-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T16:52:24Z","timestamp":1628614344000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12928-018-0517-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,5]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1,25]]}},"alternative-id":["517"],"URL":"https:\/\/doi.org\/10.1007\/s12928-018-0517-x","relation":{},"ISSN":["1868-4300","1868-4297"],"issn-type":[{"value":"1868-4300","type":"print"},{"value":"1868-4297","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,5]]},"assertion":[{"value":"1 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"T. Kimura reports position as an advisory board member of Terumo Japan and Abbott Vascular. The other authors report no disclosures with regard to the content of this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}